Promissory Notes (Tables) |
3 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2026 | ||||||||||||||||||||||||||||||||||||||||||||||
| Debt Disclosure [Abstract] | ||||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Components of Net Carrying Amount |
The following table presents the components of the net carrying amount of the DNA Note that is from a related party. This is the only note outstanding as of March 31, 2026 (in thousands of dollars): Schedule of Components of Net Carrying Amount
|
|||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Fair Value Derivative Liability |
The schedule below shows the change in the fair value of the derivative liability (in thousands of dollars): Schedule of Fair Value Derivative Liability
|
|||||||||||||||||||||||||||||||||||||||||||||
| Schedule of Interest Expense |
Schedule of Interest Expense
|
|||||||||||||||||||||||||||||||||||||||||||||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities. No definition available.
|
| X | ||||||||||
- Definition Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation. No definition available.
|
| X | ||||||||||
- Definition Tabular disclosure of derivative liabilities at fair value. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|